Trane Technologies Total Cost of Revenue decreased by 10.6% to $3.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.6%, from $3.01B to $3.24B. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.56B | $2.52B | $2.37B | $2.87B | $2.94B | $2.52B | $3.12B | $3.22B | $2.76B | $3.37B | $3.47B | $3.01B | $3.59B | $3.62B | $3.24B |
| QoQ Change | — | -1.7% | -5.9% | +21.1% | +2.5% | -14.2% | +23.7% | +3.3% | -14.5% | +22.4% | +2.8% | -13.1% | +19.1% | +1.1% | -10.6% |
| YoY Change | — | — | — | +12.0% | +16.8% | +6.6% | +8.8% | +9.7% | +9.2% | +8.1% | +7.5% | +9.3% | +6.3% | +4.5% | +7.6% |
| Segment | FY'25 |
|---|---|
| Americas | $10.91B |
| EMEA | $1.85B |
| Asia Pacific | $816.40M |
| Total | — |
All segment values are derived from annual filings.